Technology
Health
Pharmaceutical
Revance Therapeutics
$11.619876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.
$11.61
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
-$0.32 (-2.68%) Today
$0.00 (0.00%) After Hours
Why Robinhood?
You can buy or sell RVNC and other stocks, options, ETFs, and crypto commission-free!
About
Revance Therapeutics, Inc. Common Stock, also called Revance Therapeutics, is a clinical stage biotechnology company. Read More It is engaged in the development, manufacturing, and commercialization of novel botulinum toxin products for multiple aesthetic, and therapeutic applications. The firm focuses on production of daxibotulinumtoxinA, a botulinum toxin, for a broad spectrum of aesthetic and therapeutic indications, including facial wrinkles and muscle movement disorders. The company was founded by Jacob M. Waugh and L. Daniel Browne on August 10, 1999 and is headquartered in Newark, CA.
Employees
170
Headquarters
Newark, California
Founded
1999
Market Cap
510.89M
Price-Earnings Ratio
—
Dividend Yield
0.00
Average Volume
343.33K
High Today
$12.14
Low Today
$11.54
Open Price
$11.99
Volume
93.95K
52 Week High
$32.45
52 Week Low
$10.51
Collections
Technology
Health
Pharmaceutical
Therapy
Medical
Biotechnology
Manufacturing
2014 IPO
News
Yahoo FinanceMay 7
Is Revance Therapeutics Inc (RVNC) A Good Stock To Buy?
While the market driven by short-term sentiment influenced by uncertainty regarding the future of the interest rate environment in the US, declining oil prices and the trade war with China, many smart money investors kept their optimism regarding the current bull run in the fourth quarter, while still hedging many of their long positions.
Yahoo FinanceMay 1
A Spotlight On Revance Therapeutics, Inc.'s (NASDAQ:RVNC) Fundamentals
Want to participate in a short research study? Help shape the future of investing tools and you could win a $250 gift card! Building up an investment case requires looking at a stock holistically. Today I've chosen to put the spotlight on Revance Therapeutics, Inc. (NASDAQ:RVNC) due to its excellent fundamentals in more than one area. RVNC is a company with strong financial health as well as an optimistic future outlook. Below, I've touched on some key aspects you should know on a high level. For those int...
Yahoo FinanceMay 1
Will Revance Therapeutics (RVNC) Report Negative Earnings Next Week? What You Should Know
Wall Street expects a year-over-year increase in earnings on higher revenues when Revance Therapeutics (RVNC) reports results for the quarter ended March 2019. While this widely-known consensus outlook is important in gauging the company's earnings picture, a powerful factor that could impact its near-term stock price is how the actual results compare to these estimates.
Price Paid on Robinhood
37% Lower
Right Now
52 Week Low
$10.51
Average Price Paid
$18.32
52 Week High
$32.45
Earnings
-$1.12
-$0.98
-$0.85
-$0.71
Q3 2017
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Estimated
—
Actual
Expected Aug 1, After Hours